Subcutaneous abdominal, but not femoral fat expression of plasminogen activator inhibitor-1 (PAI-1) is related to plasma PAI-1 levels and insulin resistance and decreases after weight loss

Diabetologia

Volumn 44, Issue 11, 2001, Pages 2025-2031

  Mavri, A ^a   Alessi, M C ^b   Bastelica, D ^b   Geel Georgelin, O ^b   Fina, F ^c   Sentocnik, J T ^d   Stegnar, M ^a   Juhan Vague, I ^b  

^a UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^b Haematology Laboratory   (France)

^c ASSISTANCE PUBLIQUE HÔPITAUX DE MARSEILLE   (France)

^d Medical Aestetic Centre   (Slovenia)

Author keywords

Abdominal; Adipose tissue; Femoral; Obesity; PAI 1; Weight reduction

Indexed keywords

INSULIN; MESSENGER RNA; PLASMINOGEN ACTIVATOR INHIBITOR 1; TRIACYLGLYCEROL;

ABDOMEN; ADIPOSE TISSUE; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FEMUR; HUMAN; HUMAN TISSUE; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MALE; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SUBCUTANEOUS FAT; TISSUE LEVEL; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT REDUCTION;

ABDOMEN; ADIPOSE TISSUE; ADULT; BODY COMPOSITION; BODY MASS INDEX; DIET, REDUCING; FEMALE; FEMUR; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; OBESITY; PLASMINOGEN ACTIVATOR INHIBITOR 1; REFERENCE VALUES; REGRESSION ANALYSIS; RNA, MESSENGER; TRIGLYCERIDES; WEIGHT LOSS;

EID: 0035195629     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250100007     Document Type: Article

References (34)

1. Plasminogen activator inhibitor in plasma: Risk factor for recurrent myocardial infarction
2. Fibrinolytic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris
3. Correlation between blood fibrinolytic activity, plasminogen activator inhibitor level, plasma insulin level, and relative body weight in normal and obese subjects
4. Factors responsible for impaired fibrinolysis in obese subjects and NIDDM patients
5. Increased plasma plasminogen activator inhibitor 1 levels. A possible link between insulin resistance and atherothrombosis
6. Effects of troglitazone on blood concentrations of plasminogen activator inhibitor 1 in patients with type 2 diabetes and in lean and obese normal subjects
7. Fat distribution and plasminogen activator inhibitor activity in nondiabetic obese women
8. Abdominal obesity is associated with an impaired fibrinolytic activity and elevated plasminogen activator inhibitor-1
9. Visceral fat accumulation and its relation to plasma hemostatic factors in healthy men
10. Enhanced expression of PAI-1 in visceral fat: Possible contributor to vascular disease in obesity
11. Production of plasminogen activator inhibitor 1 by human adipose tissue. Possible link between visceral fat accumulation and vascular disease
12. Adipose tissue secretion of plasminogen activator inhibitor-1 in non-obese and obese individuals
13. PAI-1 produced ex vivo by human adipose tissue is relevant to PAI-1 blood level
14. Plasminogen activator inhibitor 1, transforming growth factor-beta 1, and BMI are closely associated in human adipose tissue during morbid obesity
15. Body composition and weight reduction in relation to antigen and activity of plasminogen activator inhibitor (PAI-1) in overweight individuals
16. Reduction in factor VII, fibrinogen and plasminogen activator inhibitor-1 activity after surgical treatment of morbid obesity
17. Impact of weight loss on plasminogen activator inhibitor (PAI-1), factor VII, and other hemostatic factors in moderately overweight adults
18. Prolonged very low calorie diet in obese subjects reduces factor VII and PAI but not fibrinogen levels
19. Plasminogen activator inhibitor-1, tissue-type plasminogen activator, and fibrinogen: Effect of dieting with or without exercise in overweight postmenopausal women
20. Amelioration of the inhibition of fibrinolysis in elderly, obese subjects by moderate energy intake restriction
21. Impact of adipose tissue on plasma plasminogen activator inhibitor-1 in dieting obese women
22. Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man
23. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol chloroform extraction
24. Subcutaneous adipose tissue expression of plasminogen activator inhibitor (PAI-1) in nondiabetic and type 2 diabetic subjects
25. Elevated expression of transforming growth factor-in adipose tissue from obese mice
26. Tumor necrosis factor alpha is a key component in the obesity-linked elevation of plasminogen activator inhibitor 1
27. Expression of plasminogen activator inhibitor-1 in human adipose tissue: A role for TNF?
28. Effect of tumor necrosis factor alpha and transforming growth factor beta 1 on plasminogen activator inhibitor-1 secretion from subcutaneous and omental human fat cells in suspension culture
29. TNF-alpha and insulin, alone and synergistically, induce plasminogen activator inhibitor-1 expression in adipocytes
30. Cellular characterization of adipose tissue from various body sites of women
31. Regional variation in adipose tissue metabolism of severely obese premenopausal women
32. The effect of fasting and/or body weight reduction on tissue-type plasminogen activator (t-PA) and plasminogen activator inhibitor (PAI-1)
33. Subcutaneous adipose tissue expression of plasminogen activator inhibitor-1 gene during very low calorie diet in obese subjects
34. Visceral fat as a main determinant of plasminogen activator inhibitor 1 level in women